Lidocaină Grindeks (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, stabilising them in an inactive state. This prevents the generation and conduction of action potentials, thereby interrupting nerve signal transmission and producing a reversible loss of sensation in the treated area.

The dose of Lidocaină Grindeks is determined by the prescribing clinician based on the specific procedure, route of administration, patient weight, and clinical response. Healthcare providers calculate the appropriate amount to achieve effective anesthesia while minimising toxicity.

Safety data for Lidocaină Grindeks in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Lidocaine is a widely used amide‑type local anesthetic offering rapid onset and moderate duration of action. Compared with alternatives such as bupivacaine, lidocaine has a shorter duration but a lower risk of cardiotoxicity, making it suitable for procedures requiring quick recovery of sensation.

Lidocaină Grindeks should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from direct sunlight, moisture and extreme temperatures to maintain sterility and potency.

The product is administered by a qualified professional via epidural, intramuscular or intravenous injection, depending on the clinical indication. Proper aseptic technique and dosage calculation are essential to ensure safe and effective anesthesia.

Serious risks include severe allergic reactions (anaphylaxis), cardiac arrhythmias, central nervous system toxicity such as seizures, and methemoglobinemia. Immediate medical attention is required if any of these symptoms occur during or after administration.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe hepatic impairment, and individuals with certain cardiac conduction disorders should avoid using Lidocaină Grindeks unless specifically directed by a healthcare professional.